Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2012-07-02 Regulatory Filings
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Revised Executive Agreements 23 pages 133.7KB
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The content focuses on revised executive agreements related to compensatory arrangements upon a change of control, including detailed terms of the executive agreement. It is not an annual or quarterly financial report, nor is it a proxy statement or earnings release. The document is not a full audit report or a management discussion and analysis. It is a regulatory filing disclosing material changes in executive compensation arrangements, which fits the category of Regulatory Filings (RNS) as it does not fit other more specific categories and is a standard SEC Form 8-K filing.
2012-07-02 English
4Q12 & Fiscal Year-End Results Conference Call 1 pa
Regulatory Filings Classification · 95% confidence The document is an announcement from ResMed about an upcoming conference call and webcast to discuss the fourth quarter and fiscal year-end 2012 results. It provides details on the timing, how to participate, and replay information. There is no actual financial data or detailed report content included, only an invitation and instructions for the earnings call. This fits the definition of a Call Transcript (CT) announcement, but since it is only announcing the call and not providing the transcript itself, it is best classified as a Regulatory Filing (RNS) as a general announcement. However, given the specific nature of the announcement about the earnings call, the best fit is Call Transcript (CT) category, which covers full text transcripts of company conference calls. But since this is only an announcement of the call, not the transcript, it does not meet the criteria for CT. Therefore, by the MENU VS MEAL rule, this is an announcement of a call, so it should be classified as Regulatory Filings (RNS).
2012-06-28 English
Launch of NarvalCC Mandibular Repositioning Device in the US 2 pages 383.8KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new medical device by ResMed in the US. It focuses on product introduction, market expansion, and company background. There is no financial data, regulatory filing references, shareholder information, or meeting materials. The length is 4264 characters, which is relatively short and typical for a press release. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is an announcement related to product launch and business update, which is best classified under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2012-06-13 English
Change of Director`s Interest Notice 2 pages 20.9KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as directors, officers, or significant shareholders. The document includes detailed tables of securities acquired or disposed of, transaction dates, prices, and ownership details. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document is not an annual report, earnings release, or any other type of financial or regulatory report but specifically a statement of changes in beneficial ownership. Therefore, the correct classification is Director's Dealing (DIRS).
2012-05-24 English
Omrom Launches Sleep Monitor With ResMed Technology 2 pages 89.4KB
Regulatory Filings Classification · 90% confidence The document is a press release announcing the launch of a new product, the Omron Sleep Design HSL-101, which incorporates technology from ResMed's acquisition of BiancaMed. It describes the product features, company strategies, and background information about the companies involved. There is no financial data, regulatory filing, report, or meeting-related content. The document is promotional and informational about a product launch rather than a financial or regulatory filing. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. Given the content, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2012-05-23 English
Change of Director`s Interest Notice 2 pages 22.5KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as directors, officers, or significant shareholders. The document includes detailed tables of securities acquired or disposed of, transaction dates, prices, and ownership forms. It is not an annual report, earnings release, or any other financial report but specifically a report of insider transactions. According to the filing definitions, reports of personal share transactions by company directors and executives (insider trades) are classified as Director's Dealing (DIRS). The document length and content confirm it is the actual Form 4 filing, not an announcement or certification. Therefore, the correct classification is DIRS with high confidence.
2012-05-17 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.